In carriers of CYP2D6*4 (AA), HCQ is poorly metabolized which results in reduced formation of desethyl HCQ, thus probably diminishing the efficiency of HCQ in preventing COVID-19 viruses from entering cells. This evidence concerns the gene CYP2D6 and COVID-19.